Search Results 91-100 of 13692 for direct bilirubin

1. A Study To Investigate The Effectiveness And Safety Of Pf-04965842 In Subjects Aged 12 Years And Over, With Moderate To Severe Atopic Dermatitis With The Option Of Rescue Treatment In Flaring Subjects - Mayo Clinic

   ... direct bilirubin measured and would be eligible for this study provided the direct bilirubin is ≤ ULN. In the opinion of the investigator or sponsor, have ...

2. A Phase I/II, Open-label, Multi-center Trial Of [177Lu]Lu-NeoB In Combination With Capecitabine In Adult Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression On Previous Endocrine Therapy In Combination With A CDK4/6 Inhibito - Mayo Clinic

   ... bilirubin is ≤ 3.0 × ULN or direct bilirubin ≤ 1.5 × ULN;. In absence of liver metastases, alanine aminotransferase (ALT) and aspartate aminotransferase ...

3. A Study To Evaluate The Safety And Effectiveness Of Tildacerfont To Reduce Glucocorticoid Use In Classic Congenital Adrenal Hyperplasia - Mayo Clinic

   Total bilirubin >1.5 x ULN (isolated total bilirubin >1.5 x ULN is acceptable if bilirubin is fractionated and direct bilirubin is 5 x ULN Routinely works ...

4. Daunorubicin Hydrochloride, Cytarabine, And Nilotinib In Treating Patients With Newly Diagnosed Acute Myeloid Leukemia - Mayo Clinic

   Total bilirubin =< 1.5 x ULN (does not apply to patients with isolated hyperbilirubinemia [e.g., Gilbert's disease], in that case direct bilirubin should be =< ...

5. Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma - Mayo Clinic

   Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN) OR, if total bilirubin is > 1.5 x ULN, the direct bilirubin must be normal; SGOT (AST) ...

6. Pembrolizumab In Treating Participants With Recurrent Ovarian Cancer - Mayo Clinic

   Performed within 10 days of treatment initiation: serum total bilirubin ≤ 1.5 x ULN OR direct bilirubin ≤ ULN for subjects with total bilirubin levels > 1.5 ...

7. A Study to Establish an Alcoholic Hepatitis Network - Mayo Clinic

   Conjugated bilirubin: > ULN;; INR: > 1.4;; AST: >40 IU/mL;; ALT: >40 IU/mL. Based on the judgment of the investigator, subject is not capable of complying with ...

8. Ibrutinib In Treating Minimal Residual Disease In Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy - Mayo Clinic

   Total bilirubin =< 1.5 mg/dL or direct bilirubin =< 1.0 mg/dL for patients with Gilbert's syndrome;. Serum glutamic oxaloacetic transaminase (SGOT) ...

9. Tipifarnib In Subjects With Chronic Myelomonocytic Leukemia, Other Myelodysplastic /Myeloproliferative Neoplasias, And Acute Myeloid Leukemia - Mayo Clinic

   Participation eligibility · Total or direct bilirubin ≤ 2 times upper limit of normal (x ULN); does not apply to subjects with Gilbert's syndrome diagnosed as ...

10. Efficacy And Safety Of Treatment With Alpelisib Plus Endocrine Therapy In Patients With HR+, HER2-negative ABC, With PIK3CA Mutations, Whose Disease Has Progressed On Or After CDK 4/6 Treatment With An Aromatase Inhibitor (AI) Or Fulvestrant - Mayo Clinic

    ... bilirubin is ≤ 3.0 × ULN or direct bilirubin ≤ 1.5 × ULN. Patient has adequate renal function: Serum creatinine ≤ 1.5 x ULN or creatinine clearance ≥ 35 ...